tm logo
XUNDRIA
ABANDONED SECTION 36

on 10 Jul 2018

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1812275 filed on 01st Dec 2016

XUNDRIA

Trademark usage description

pharmaceutical preparations, namely pharmaceutical preparations for the diagnosis and treatment of alzheimer's, anxiety disorders, atherosclerosis, au Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely pharmaceutical preparations for the diagnosis and treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders, namely anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms and hot flashes, inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, namely metabolic syndrome, migraines, muscle diseases and disorders, namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders, namely Huntington's disease, Dementia and Parkinson's disease, neurological disorders, namely mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, pancreatic diseases and disorders, psychiatric disorders, namely acute stress disorder, substance abuse, delusions and hallucinations, sleep disorders, urological disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases


Classification kind code

10

Mark Details


Serial Number

1812275

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 10th Jul 2018
Abandoned - Section 36
Submitted for opposition 14
on 17th Apr 2018
Default Notice Sent
Submitted for opposition 22
on 29th Sep 2017
Search Recorded
Submitted for opposition 20
on 29th Sep 2017
Examiner's First Report
Submitted for opposition 1
on 02th Dec 2016
Created
Submitted for opposition 31
on 02th Dec 2016
Formalized
Submitted for opposition 30
on 01st Dec 2016
Filed